


Ask a doctor about a prescription for RYALTRIS 25 micrograms/600 micrograms/per actuation nasal spray suspension
Package Leaflet: Information for the Patient
Ryaltris 25 micrograms/600 micrograms per actuation, nasal spray suspension
mometasone furoate/olopatadine
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Contents of the pack
Ryaltris contains two active substances: mometasone furoate and olopatadine.
Ryaltris is used to treat the symptoms of moderate to severe seasonal allergic rhinitis(also known as hay fever) and perennial allergic rhinitisin adults and adolescents 12 years and older.
Seasonal allergic rhinitis(hay fever) is an allergic reaction that occurs at certain times of the year and is caused by inhaling pollen from trees, grasses, weeds, and also molds and fungal spores.
Perennial allergic rhinitisoccurs throughout the year and symptoms can be caused by sensitivity to a variety of things including house dust mites, animal hair (or dander), feathers, and certain foods.
Ryaltris relieves the symptoms of allergies, such as nasal discharge, sneezing, itching, and nasal congestion.
Do not use Ryaltris
Warnings and precautions
Consult your doctor or pharmacist before you start using Ryaltris
Consult your doctor or pharmacist while you are using Ryaltris
If nasal corticosteroid sprays are used at high doses for long periods of time, side effects can occur due to the medicine being absorbed into the body. These side effects can include weight loss, fatigue, muscle weakness, low blood sugar levels, low sodium levels, joint pain, depression, and skin darkening. If you experience any of these side effects, your doctor may recommend a different medicine during periods of stress or scheduled surgeries.
If you are not sure if the above applies to you, consult your doctor or pharmacist before using Ryaltris.
Children and adolescents
Ryaltris is not recommended for children under 12 years of age.
Using Ryaltris for a long period of time may cause children and adolescents to grow more slowly. Your doctor will regularly check your child's heightand make sure they are taking the lowest effective dose possible.
Other medicines and Ryaltris
Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines.
If you are taking other corticosteroids for your allergy, either by mouth or by injection, your doctor may advise you to stop taking them when you start using Ryaltris.
If you are taking other medicines by mouth or using them locally (eye drops or nasal sprays) that contain olopatadine or other antihistamines, your doctor may recommend that you stop taking them once you start using Ryaltris.
Some medicines may increase the effects of Ryaltris, so your doctor will monitor you closely if you are taking these medicines (including some for HIV: ritonavir, cobicistat).
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.
Ryaltris should not be used during pregnancy unless your doctor considers it necessary.
If you are using Ryaltris, your doctor will confirm with you whether you should breastfeed your baby, taking into account the benefit to you of the treatment and the benefit of breastfeeding your baby. You should not do both.
Driving and using machines
Very rarely, you may experience dizziness, drowsiness, fatigue, and sleepiness. If this happens, do not drive or use machinery. Note that drinking alcohol can enhance these effects.
Ryaltris contains benzalkonium chloride
This medicine contains 0.02 mg of benzalkonium chloride in each nasal spray.
Benzalkonium chloride may cause irritation or inflammation inside the nose, especially when used for long periods of treatment.
Follow the instructions for administration of this medicine exactly as told by your doctor or pharmacist. If you are not sure, consult your doctor or pharmacist again.
Avoid contact with the eyes.
Adults and adolescents (12 years of age and older)
The recommended dose is two sprays in each nostrilin the morning and in the evening.
Use in children under 12 years of age
This medicine is not recommended for children under 12 years of age.
Method of administration
The spray is for nasal use.
Read the following instructions carefully and use the spray only as directed.
Shake the bottle for at least 10 seconds before each use.
When Ryaltris is not in use, the purple cap should always be kept firmly on the white tip of the nozzle.
Ryaltris nasal spray bottle

Preparing the bottle for nasal spray


How to use the nasal spray





Cleaning your nasal spray
If the nozzle becomes blocked, follow the steps below:
If you use more Ryaltris than you should
It is unlikely that you will have any problems, but if you are concerned or if you have used higher doses than recommended for a long time, consult your doctor.
If you use steroids for a long time or in large amounts, they can, in rare cases, affect some of your hormones. In children, it can affect growth and development.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, telephone 91 562 04 20, stating the medicine and the amount taken.
If you forget to use Ryaltris
If you forget to use your nasal spray at the right time, use it as soon as you remember, then follow your normal routine of administration. Do not use a double dose to make up for forgotten doses.
If you stop using Ryaltris
It is very important that you use your nasal spray regularly. Do not stop your treatment even if you feel better, unless your doctor tells you to.
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Immediate allergic reactions (hypersensitivity) can occur after using this medicine. These reactions can be serious. You should stop using Ryaltris and seek medical help immediately if you experience symptoms such as: swollen face, tongue, or pharynx, difficulty swallowing, hives, fatigue, or difficulty breathing.
Common (may affect up to 1 in 10 people):
Uncommon (may affect up to 1 in 100 people):
Rare (may affect up to 1 in 1,000 people):
Frequency not known (frequency cannot be estimated from the available data):
Systemic side effects (side effects that affect the whole body) can occur when this medicine is used at high doses for a long time. It is much less likely that these effects will occur if you use a nasal steroid spray than if you take steroids by mouth. These effects can vary depending on the patient.
Nasal steroids can affect the normal production of hormones in your body, particularly if you use high doses for a long time. In children and adolescents, this side effect can cause them to grow more slowly than others.
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the bottle and carton after "EXP". The expiry date is the last day of the month stated. Do not freeze. The spray should be used within 2 months of first use.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Ryaltris composition
Product appearance and container contents
Ryaltris is a white and homogeneous suspension.
Ryaltris is presented in a white high-density polyethylene bottle with a manual polypropylene spray pump, with a calibrated dose. The nasal applicator is equipped with a violet PEAD cap.
Container sizes:
1 bottle of 20 ml with 56 sprays
1 bottle of 20 ml with 120 sprays
1 bottle of 30 ml with 240 sprays
Only some container sizes may be marketed.
Marketing authorization holder and manufacturer
Marketing authorization holder
Glenmark Pharmaceuticals s.r.o.
Hvezdova 1716/2b
140 78 Praha 4
Czech Republic
Manufacturer
Glenmark Pharmaceuticals s.r.o.
Fibichova 143, 566 17 Vysoke Myto
Czech Republic
You can request more information about this medicine by contacting the local representative of the marketing authorization holder:
Laboratorios Menarini, S.A.
Alfons XII, 587
08918 Badalona (Barcelona)
Spain
This medicine is authorized in the EEA member states under the following names:
Germany | Ryaltris 25 micrograms/600 micrograms per spray Nasal Spray, Suspension. |
Austria | RYALTRIS 25 micrograms/600 micrograms per spray Nasal Spray, Suspension |
Belgium | RYALTRIS 25 micrograms/spray + 600 micrograms/spray, suspension for nasal spray RYALTRIS 25 microgram/spray + 600 microgram/spray, nasal spray, suspension RYALTRIS 25 micrograms/spray + 600 micrograms/spray Nasal Spray, Suspension |
Denmark | Ryaltris 25 micrograms/600 micrograms per dose Nasal Spray, suspension |
Slovakia | RYALTRIS 25 micrograms/600 micrograms in one spray nasal suspension aerosol |
Spain | Ryaltris 25 micrograms/600 micrograms/pulse, suspension for nasal spray |
Finland | RYALTRIS 25 micrograms + 600 micrograms / dose nasal spray, suspension |
France | RYALTRIS 25 micrograms/600 micrograms, suspension for nasal spray |
Ireland | Ryaltris 25 micrograms/actuation + 600 micrograms/actuation nasal spray, suspension |
Italy | RYALTRIS 25 micrograms/600 micrograms per delivery Nasal Spray, suspension |
Norway | RYALTRIS |
Netherlands | RYALTRIS 25 micrograms/600 micrograms, nasal spray, suspension |
Poland | RYALTRIS |
United Kingdom | RYALTRIS 25 micrograms/600 micrograms per actuation Nasal Spray, suspension |
Czech Republic | RYALTRIS |
Romania | RYALTRIS 25 micrograms/600 micrograms/dose nasal spray suspension |
Sweden | Ryaltris, 25 micrograms/puff + 600 micrograms/puff, Nasal Spray, suspension |
Date of the last revision of this leaflet:July 2024.
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/).
The average price of RYALTRIS 25 micrograms/600 micrograms/per actuation nasal spray suspension in November, 2025 is around 14.75 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for RYALTRIS 25 micrograms/600 micrograms/per actuation nasal spray suspension – subject to medical assessment and local rules.